A Phase I, Single-Centre, Randomised, Double-Blind, Placebo-controlled, Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Japanese Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2010
At a glance
- Drugs AZD 7268 (Primary)
- Indications Depression
- Focus Adverse reactions
- 16 Nov 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 16 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2010 New trial record